Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tetragenex Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tetragenex Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Tetragenex Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is TTRX. The reporting company's CIK number is 1362659.
The total value of stock buying since 2005 is $6,900.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2007-11-29||Cohen Aaron (Director)||Buy||10,000||.34||3,400|
|2007-11-26||Cohen Aaron (Director)||Buy||10,000||.35||3,500|
Insider trading activities including stock purchases, stock sales, and option exercises of TTRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tetragenex Pharmaceuticals, Inc. (symbol TTRX, CIK number 1362659) see the Securities and Exchange Commission (SEC) website.